<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-59</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>THE ROLE OF CIRCULATING ANTIPHOSPHOLIPID ANTIBODIES IN THE FETAL LOSS SYNDROME DEVELOPMENT</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ ЦИРКУЛИРУЮЩИХ АНТИФОСФОЛИПИДНЫХ АНТИТЕЛ В РАЗВИТИИ СИНДРОМА ПОТЕРИ ПЛОДА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селхаджиева</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Selkhadzhieva</surname><given-names>M. S.</given-names></name></name-alternatives><email xlink:type="simple">gemostasis@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Первый МГМУ имени И.М. Сеченова» Минздрава РФ, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>The State Education Institution of Higher Professional Training The First Sechenov Moscow State Medical University under Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>07</day><month>06</month><year>2016</year></pub-date><volume>8</volume><issue>1</issue><fpage>31</fpage><lpage>33</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Selkhadzhieva M.S., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Селхаджиева М.С.</copyright-holder><copyright-holder xml:lang="en">Selkhadzhieva M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/59">https://www.gynecology.su/jour/article/view/59</self-uri><abstract><p>The article describes the examination data of pregnant women with fetal loss syndrome in anamnesis which were analyzed for the circulated antiphospholipid antibodies. Reviewed approaches to prevention of obstetrics complication and antithrombotic prophylaxis with LMWH.</p></abstract><trans-abstract xml:lang="ru"><p>В статье изложены материалы обследования беременных с синдромом потери плода в анамнезе, у которых проводился анализ циркулирующих антифосфолипидных антител. Дается научное обоснование необходимости противотромботической профилактики низкомолекулярными гепаринами.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ТРОМБОФИЛИЯ</kwd><kwd>СИНДРОМ ПОТЕРИ ПЛОДА</kwd><kwd>АНТИФОСФОЛИПИДНЫЙ СИНДРОМ</kwd><kwd>ПРОФИЛАКТИКА ТРОМБОЗОВ</kwd><kwd>ГЕСТОЗ</kwd><kwd>ОСЛОЖНЕННАЯ БЕРЕМЕННОСТЬ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thrombophilia</kwd><kwd>fetal loss syndrome</kwd><kwd>antiphospholipid syndrome</kwd><kwd>thrombosis prevention</kwd><kwd>preeclampsia</kwd><kwd>complicated pregnancy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бицадзе В.О. Патогенез, принципы диагностики и профилактики осложнений беременности, обусловленных тромбофилией. Дисс. …докт. мед. наук. М. 2004; 271 с.</mixed-citation><mixed-citation xml:lang="en">Bicadze V.O. Patogenez, principy diagnostiki i profilaktiki oslozhnenij beremennosti, obuslovlennyh trombofiliej. Diss. …dokt. med. nauk. M. 2004; 271 s.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Громыко Г.Л. Роль антифосфолипидного синдрома в развитии акушерских осложнений. Проблемы репродукции. 1997; 4: 13-18.</mixed-citation><mixed-citation xml:lang="en">Gromyko G.L. Rol' antifosfolipidnogo sindroma v razvitii akusherskih oslozhnenij. Problemy reprodukcii. 1997; 4: 13-18.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д. Антифосфолипидный синдром М. 2000; 373 с.</mixed-citation><mixed-citation xml:lang="en">Makacarija A.D. Antifosfolipidnyj sindrom M. 2000; 373 s.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Макацария А.Д., Бицадзе В.О. Тромбофилии и противотромботическая терапия в акушерской практике. М. 2003; 904 с.</mixed-citation><mixed-citation xml:lang="en">Makacarija A.D., Bicadze V.O. Trombofilii i protivotromboticheskaja terapija v akusherskoj praktike. M. 2003; 904 s.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Матвеева Т.Е. Вопросы патогенеза и профилактики синдрома потери плода у беременных с тромбофилией. Дисс. ...канд. мед. наук. М. 2002; 131 с.</mixed-citation><mixed-citation xml:lang="en">Matveeva T.E. Voprosy patogeneza i profilaktiki sindroma poteri ploda u beremennyh s trombofiliej. Diss. ...kand. med. nauk. M. 2002; 131 s.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сухих Г.Л., Пономарева И.В., Городничева Ж.А., Ванько Л.В. Спектр антифосфолипидных антител у беременных с гестозом. Акушерство и гинекология. 1998; 5: 22-26.</mixed-citation><mixed-citation xml:lang="en">Suhih G.L., Ponomareva I.V., Gorodnicheva Zh.A., Van'ko L.V. Spektr antifosfolipidnyh antitel u beremennyh s gestozom. Akusherstvo i ginekologija. 1998; 5: 22-26.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Amergual O., Atsumi T., Khamashta M.A, Tinohones F., Hughes G.R.V. Autoantibodies against oxidazed low density lipoprotein in antiphospholipid syndrome. Br. J. Rheumatol. 1997; 36: 964-968.</mixed-citation><mixed-citation xml:lang="en">Amergual O., Atsumi T., Khamashta M.A, Tinohones F., Hughes G.R.V. Autoantibodies against oxidazed low density lipoprotein in antiphospholipid syndrome. Br. J. Rheumatol. 1997; 36: 964-968.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Backos M., Rai R., Baxter N., Chilcott I.T, Cohen H., Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low-dose aspirin and heparin. Br. Obstet Gynaecol. 1999; 106: 102-7.</mixed-citation><mixed-citation xml:lang="en">Backos M., Rai R., Baxter N., Chilcott I.T, Cohen H., Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low-dose aspirin and heparin. Br. Obstet Gynaecol. 1999; 106: 102-7.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Evidence-Based Clinical Practice Guidelines American College of Chest Physicians (8th Edition). Chest. 2008; 133; 844-886.</mixed-citation><mixed-citation xml:lang="en">Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J. Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Evidence-Based Clinical Practice Guidelines American College of Chest Physicians (8th Edition). Chest. 2008; 133; 844-886.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Botet F., Romera G., Montagut P., Figueras J., Carmona J., Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J. Perinat. Med. 1997; 25: 192-196.</mixed-citation><mixed-citation xml:lang="en">Botet F., Romera G., Montagut P., Figueras J., Carmona J., Balasch J. Neonatal outcome in women treated for the antiphospholipid syndrome during pregnancy. J. Perinat. Med. 1997; 25: 192-196.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cowchock S. Antibodies and pregnancy loss. The New Eng. Journal of Medicine. July 17, 1997; 197-198.</mixed-citation><mixed-citation xml:lang="en">Cowchock S. Antibodies and pregnancy loss. The New Eng. Journal of Medicine. July 17, 1997; 197-198.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">de Laat B., Mertens K., de Groot Ph. Mechanisms of disease: antiphospholipid antibodies -from clinical association to pathologic mechanism nature clinical practice / B. de Laat, K. Mertens, Ph. de Groot. Rheumatology. 2008; 4 (4): 192-199.</mixed-citation><mixed-citation xml:lang="en">de Laat B., Mertens K., de Groot Ph. Mechanisms of disease: antiphospholipid antibodies -from clinical association to pathologic mechanism nature clinical practice / B. de Laat, K. Mertens, Ph. de Groot. Rheumatology. 2008; 4 (4): 192-199.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Empson M., Lassere M., Craig J.C., Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet. Gynecol. 2002; 99:135-44.</mixed-citation><mixed-citation xml:lang="en">Empson M., Lassere M., Craig J.C., Scott J.R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet. Gynecol. 2002; 99:135-44.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Farquharson R.G., Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 2002; l00: 408-13.</mixed-citation><mixed-citation xml:lang="en">Farquharson R.G., Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 2002; l00: 408-13.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gandra M.J., Fraga M., Saraiva J.P., Andrade J. Anticardiolipin antibodies and high risk pregnancy. 16th Congress on thromb and haemost. Porto. 2000; abstr. p. 160.</mixed-citation><mixed-citation xml:lang="en">Gandra M.J., Fraga M., Saraiva J.P., Andrade J. Anticardiolipin antibodies and high risk pregnancy. 16th Congress on thromb and haemost. Porto. 2000; abstr. p. 160.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Genievskaya M., Makatsaria A. Low molecular weight heparin (Fraxiparine) as long-term single agent therapy in pregnant with antiphospholipid syndrome. 16th Congress oh thrombosis and haemostasis. Porto. 2000, abstr. p. 161.</mixed-citation><mixed-citation xml:lang="en">Genievskaya M., Makatsaria A. Low molecular weight heparin (Fraxiparine) as long-term single agent therapy in pregnant with antiphospholipid syndrome. 16th Congress oh thrombosis and haemostasis. Porto. 2000, abstr. p. 161.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Granger K.A., Farquharson R.G., Obstetric outcome in antiphosholipid syndrome. Lupus. 1997; 6: 509-513.</mixed-citation><mixed-citation xml:lang="en">Granger K.A., Farquharson R.G., Obstetric outcome in antiphosholipid syndrome. Lupus. 1997; 6: 509-513.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Honig A. Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages / A. Honig et al. Hum. Reprod. 2010; 25 (11): 2753-2754.</mixed-citation><mixed-citation xml:lang="en">Honig A. Pregnancy-triggered antiphospholipid syndrome in a patient with multiple late miscarriages / A. Honig et al. Hum. Reprod. 2010; 25 (11): 2753-2754.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Levy R.A., Avvad E., Olivera J., Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus. 1998; 7 (2): 81-85.</mixed-citation><mixed-citation xml:lang="en">Levy R.A., Avvad E., Olivera J., Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus. 1998; 7 (2): 81-85.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lyden T.W., Vogt E., Ng A.K., Johnson P.M., Rote N.S. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. Reprod Immunol. 1992; 22: 1-14.</mixed-citation><mixed-citation xml:lang="en">Lyden T.W., Vogt E., Ng A.K., Johnson P.M., Rote N.S. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. Reprod Immunol. 1992; 22: 1-14.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Zeev Blumenfeld, Benjamin Brenner. Thrombophilia-associated pregnancy wastage. Fertility and sterility. Nov. 1999; 72 (5): 765-774.</mixed-citation><mixed-citation xml:lang="en">Zeev Blumenfeld, Benjamin Brenner. Thrombophilia-associated pregnancy wastage. Fertility and sterility. Nov. 1999; 72 (5): 765-774.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
